KLRK1 and melanoma: For example, IFN-γ downregulates NKG2D ligand expression in melanoma cells which impairs NKG2D-mediated cytolysis of MHC class I-deficient melanoma by NK cells [95], and IL-15 can partially overcome this tumour escape mechanism [96].